TruVenturo is a Hamburg-based venture capital firm and company builder founded in 2009 by serial entrepreneur Nils Regge, specializing in co-founding and scaling digital ventures with a focus on innovative technologies and transformative business models. It operates as a single-family office and maintains a strong focus on digital innovation, longevity, and neuroscience-driven solutions. Compared with traditional VCs, TruVenturo stands out for its "company builder" model, where it works side-by-side with founders to turn bold ideas into market leaders.

Its investment interests span a wide range of sectors including life sciences, consumer tech, and travel, with a specific thesis in brain-computer interfaces (BCI) and pharma to prolong healthy human lifespan. The firm's approach is rooted in identifying big future markets and providing both capital and operational resources—such as its development arm, DevelopX—to early-stage tech and biotech startups. This makes it especially relevant to founders seeking deep entrepreneurial expertise and a partner willing to be deeply involved in the scaling process.

TruVenturo is primarily focused on Germany-based startups but maintains a global network and has made investments in the United States and Australia. For neurotech founders, it is a key fund to track because of its explicit mandate in neuroscience and its history of backing significant players in the space, such as Rune Labs and INBRAIN Neuroelectronics. It is most relevant for early-stage companies—specifically at the Pre-Seed and Seed stages—that align with its long-term vision of real-world impact and value creation.